U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): April 25, 2001

AMEDISYS, INC.
(Exact Name of Registrant as Specified in Charter) 

                          Delaware
                          --------
               (State or Other Jurisdiction of
               Incorporation or Organization)

       0-24260                            11-3131700
      --------                            ----------
(Commission File Number)       (I.R.S. Employer Identification No.)

11100 Mead Road, Suite 300, Baton Rouge, LA
70816 (Address of principal executive offices
including zip code)

(225) 292-2031
(Registrant's telephone number, including area code)

ITEM 5. OTHER EVENTS

On April 25, 2001, Amedisys, Inc., "the Company" issued a press release attached hereto as Exhibit 99.1 to announce that the Company will release quarter ended March 31, 2001 operating results on May 1, 2001 and will also host a conference call at 4:15 p.m. EDT on the same day.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(a) Financial Statements of Business Acquired.

Not applicable.

(b) Pro Forma Financial Information.

Not applicable.

(c) Exhibit 

  No.

                                                            Page
                                                            -----

99.1(i)  Press Release dated April 25, 2001 announcing
         that the Company will release quarter ended
         March 31, 2001 operating results on May 1, 2001
         and will also host a conference call at 4:15 p.m.
         EDT on the same day................................. A-1

         (i)  Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMEDISYS, INC. 

By:  /s/ John M. Joffrion
   -----------------------------------------------------
John M. Joffrion
Senior Vice President of Finance
Principal Accounting and Financial Officer

DATE: April 25, 2001

INDEX TO EXHIBITS 

EXHIBIT
NUMBER         DESCRIPTION                                                         PAGE
-------        -----------                                                         ----
99.1(i)        Press Release dated April 25, 2001 announcing that
               the Company will release quarter ended March 31,
               2001 operating results on May 1, 2001 and will
               also host a conference call at 4:15 p.m. EDT on
               the same day ....................................................... A-1

(i) Filed herewith.

EXHIBIT 99.1

For Immediate Release

AMEDISYS TO HOST CONFERENCE CALL
TO DISCUSS FIRST QUARTER
FINANCIAL PERFORMANCE AND OPERATING RESULTS

BATON ROUGE, Louisiana (April 25, 2001) - Amedisys, Inc. (OTC BB: "AMED"), one of America's leading home health nursing companies, today announced that it plans to release its operating results for the quarter ended March 31, 2001 on May 1, 2001. The Company will also host a conference call with the investment community at 4:15 p.m. EDT the same day.

TO PARTICIPATE IN THE CONFERENCE CALL, PLEASE DIAL (800) 388-8975 A FEW MINUTES BEFORE 4:15 P.M. EDT ON MAY 1, 2001. A REPLAY OF THE CONFERENCE CALL WILL BE AVAILABLE UNTIL MAY 8, 2001, BY DIALING (800) 428-6051. THE ACCESS CODE IS #183994 FOR THE REPLAY.

Amedisys, Inc. is a leading multi-regional provider of home health nursing services and is headquartered in Baton Rouge, Louisiana. Its common stock trades on the OTC Bulletin Board under the symbol "AMED".

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Additional information on this Company can be found on the World Wide Web

http://www.amedisys.com

For further information, please contact:

John Joffrion, Senior Vice President at (225) 292-2031 or RJ Falkner & Company, Inc., Investor Relations Counsel at (800) 377-9893 or via e-mail at info@rjfalkner.com